Image via Mobihealth News
Last updated
Bristol Myers Squibb: Partnership
Bristol Myers Squibb partners with China's Hengrui Pharma on a $15.2 billion deal to advance more than a dozen early-stage drugs
Source: Mobihealth News
The leadership read
Alliances like this can broaden biotech & pharma commercial leadership bench strength.
Market context: MitchelLake's Talent Market Index sits at 111.2 (Hot), up 5.2 on the prior month; Asia hiring signal is running rising (+3.7pts).
Bristol Myers Squibb: 3 signals in the last 90 days — above the Biotech & Pharma median of 1 across 24 tracked companies; 0.3% of MitchelLake's Asia signal flow; 3 tracked across 37 days.
MitchelLake in this thematic
Also at Bristol Myers Squibb →
More signals across Biotech & Pharma
Restructuring · Asia
Samsung Biologics →Samsung Biologics unionized workers voted to leave the Samsung Group United Union and form an independent labor union, following months of work-to-rule campaigns and strikes over pay and working conditions.
Geographic Expansion · Asia
Thermo Fisher Scientific →Thermo Fisher Scientific's Manila Shared Services Centre is scaling rapidly from 100 to ~700 employees by 2026, positioning itself as a high-impact regional hub for Asia-Pacific operations with focus on digital transformation and strategic value creation beyond cost efficiency.
Capital Raising · Asia
Legend Biotech →First Beijing Investment Ltd acquired $43.78 million stake (2.3M shares) in Legend Biotech, a cancer cell therapy developer
Geographic Expansion · Asia
Promomed Group →Promomed Group (Russian pharmaceutical company) is expanding into Vietnam's pharmaceutical market with strategic partnerships. Founder Petr Bely met with Vietnam's Minister of Health to discuss long-term cooperation, technology transfer, and manufacturing operations targeting innovative drugs, biosimilars, and monoclonal antibodies
Ma Activity · Asia
Gilead Sciences →Gilead Sciences agreed to acquire Ouro Medicines for up to $2.18 billion, gaining rights to antibody drug licensed from China's Keymed Biosciences
Partnership · Americas
Basecamp Research →Basecamp Research integrated its EDEN antibiotic and vaccine design models into Claude Science, enabling scientists to design antibiotics and prioritize vaccine targets through Claude's interface.
Intelligence powered by Autonodal ↗